Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically

Amyotrophic Lateral Sclerosis

Volumn 12, Issue 5, 2011, Pages 340-344

  Paizs, Melinda ^a   Tortarolo, Massimo ^b   Bendotti, Caterina ^b   Engelhardt, József I ^c   Siklós, László ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

AMPA receptor; Intracellular calcium; Motor neuron; MSOD1 model; Talampanel

Indexed keywords

CALCIUM; COPPER ZINC SUPEROXIDE DISMUTASE; TALAMPANEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASYMPTOMATIC DISEASE; CALCIUM CELL LEVEL; CELL ASSAY; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; MOTONEURON; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD NERVE CELL;

ANIMALS; BENZODIAZEPINES; CALCIUM; HUMANS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MOTOR NEURONS; SUPEROXIDE DISMUTASE;

EID: 80053933805     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2011.584627     Document Type: Article

References (29)

1. Eisen A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle Nerve. 1995;18:741-52.
2. Geser F, Brandmei NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol. 2008;65:636-41. (Pubitemid 351679659)
3. Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol. 2009;187:761-72.
4. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65:S3-9.
5. Bogaert E, d' Y dewalle C, van den Bosch L. Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanisms to therapeutic target. CNS & Neurol Disord Drug Targets. 2010;9:297-304.
6. Siciliano G, Carlesi C, Pasquali L, Piazza S, Pietracupa S, Fornai L, et al. Clinical trials for neuroprotection in ALS. CNS & Neurol Disord Drug Targets. 2010;9:305-13.
7. van den Bosch L, van Damme P, Bogaert E, Robberech W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta. 2006;1762:1068-82. (Pubitemid 44781176)
8. van Damme P, Leyssen M, Callewaert G, Robberecht W, van den Bosch L. The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis. Neurosci Lett. 2003;343:81-4. (Pubitemid 36577521)
9. Tortarolo M, Grignaschi G, Calvaresi N, Zennaro E, Spaltro G, Colovic M, et al. Glutamate AMPA receptors change in motor neurons of SOD1-G93A transgenic mice and their inhibition by a non-competitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J Neurosci Res. 2006;83:134-46. (Pubitemid 43062017)
10. Howes JF, Bell C. Talampanel. Neurotherapeutics. 2007;4: 126-9. (Pubitemid 46107320)
11. Pascuzzi RM, Shefner J, Chappell AS, Bjerke JS, Tamura R, Chaudhry V, et al. A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:266-71.
12. Paizs M, Engelhardt JI, Katarova Z, Sikló s L. Hypoglossal motor neurons display a reduced calcium increase after axotomy in mice with up-regulated parvalbumin. J Comp Neurol. 2010;518:1946-61.
13. 2+ accumulation in CA1 pyramidal cells after cerebral ischaemia in newborn pigs. Brain Res. 2004;1019:97-104. (Pubitemid 39078615)
14. Vígh L, Smith RG, Soós J, Engelhardt JI, Appel SH, Sikló s L. Sublethal dose of 4-hydroxynonenal reduces intracellular calcium in surviving motor neurons in vivo. Acta Neuropathol. 2005;109:567-75. (Pubitemid 40974145)
15. Pizzasegola C, Caron I, Daleno C, Ronchi A, Minoia C, Carri MT, et al. Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. Amyotroph Lateral Scler. 2009;10:221-8.
16. Beers DR, Ho B-K, Siklós L, Alexianu ME, Mosier DR, Mohamed AH, et al. Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J Neurochem. 2001;79:499-509. (Pubitemid 33029923)
17. Sikl ós L, Engelhardt JI, Alexianu ME, Gurney ME, SiddiqueT, Appel SH. Intracellular calcium parallels motor neuron degeneration in SOD1 mutant mice. J Neuropathol Exp Neurol. 1998;57:571-87. (Pubitemid 28265600)
18. Borgers M, de Brabander DM, van Reempts DJ, Awouters F, Jacob WA. Intranuclear microtubules in lung mast cells of guinea pigs in anaphylactic shock. Lab Invest. 1977;37:1-8. (Pubitemid 8145769)
19. Borgers M, Thoné F, van Neuten JM. The subcellular distribution of calcium and the effects of calcium antagonists as evaluted with a combined oxalate-pyroantimonate technique. Acta Histochem. 1981;S24:327-32.
20. Probst W. Ultrastructural localization of calcium in the CNS of vertebrates. Histochem. 1986;85:231-9.
21. Buchs P-A, Stoppini L, Pá r ducz A, Siklós L, Muller D. A new cytochemical method for the ultrastructural localization of calcium in the central nervous system. J Neurosci Meth. 1994;54:83-93. (Pubitemid 24287248)
22. Adalbert R, Engelhardt JI, Sikl ós L. DL-homocysteic acid application disrupts calcium homeostasis and induces degeneration of spinal motor neurons in vivo. Acta Neuropathol. 2002;103:428-36. (Pubitemid 36075337)
23. Engelhardt JI, Siklós L, Appel SH. Altered calcium homeostasis and ultrastructure in motor neurons of mice caused by passively transferred anti-motoneuronal IgG. J Neuropathol Exp Neurol. 1997;56:21-39. (Pubitemid 127470324)
24. Kittel Á , Sikl ós L, Thuró c zy G, Somosy Z. Qualitative enzyme histochemistry and microanalysis reveals changes in ultrastructural distribution of calcium and calcium-activated ATPases after microwave irradiation of the medial habenula. Acta Neuropathol. 1996;92:362-8. (Pubitemid 26317103)
25. Sikl ós L, Kuhnt U, P ár ducz Á , Szerdahelyi P. Intracellular calcium redistribution accompanies changes in total tissue Na+, K+ and water during the fi rst two hours of in vitro incubation of hippocampal slices. Neuroscience. 1997;79: 1013-22. (Pubitemid 27293755)
26. Somosy Z, Kovács J, Siklós L, Köteles GJ. Morphological and histochemical changes in intercellular junctional complexes in epithelial cells of mouse small intestine upon X-irradiation: changes of ruthenium red permeabiliy and calcium content. Scanning Microscopy. 1993;7:961-71. (Pubitemid 24059204)
27. Sikl ós L, Engelhardt JI, Harati Y, Smith RG, Joó F, Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann Neurol. 1996;39:203-16. (Pubitemid 26071571)
28. Ludolph AC, Bendotti C, Blaugrund E, Chio A, Greensmith L, Loeffl er J-P, et al. Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotroph Lateral Scler. 2010;11:38-45.
29. Wagner KR. The need for biomarkers in amyotrophic lateral sclerosis drug development. Neurology. 2009;72:11-2.